Marisa Wexler, MS,  senior science writer—

Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.

Articles by Marisa Wexler

Aerobic exercise may help Parkinson’s patients after DBS

Aerobic exercise may help relieve non-motor symptoms of Parkinson’s disease in people who have undergone deep brain stimulation (DBS), a small study suggested. The researchers said there’s a need for more studies on exercise and Parkinson’s patients who have had DBS, a surgical treatment that involves implanting an electrode…

Analyzing emotional reactions could aid Parkinson’s diagnosis

Tracking how the brain responds to different emotions may be an effective way to detect Parkinson’s disease, a new study posits. The study, “Exploring Electroencephalography-Based Affective Analysis and Detection of Parkinson’s Disease,” was published in Intelligent Computing. Along with its characteristic motor symptoms, Parkinson’s can…

Syndication model seen accelerating progress in digital healthcare

A syndication model being explored in a Parkinson’s disease study may help accelerate digital healthcare by speeding the development of digital tools to track disease activity, according to a published paper. “The syndication model combines the speed of single sponsor studies with the advantage of having multi-member expertise and…

HL192 well tolerated in volunteers in Parkinson’s clinical trial

HL192, an experimental oral therapy being developed to treat Parkinson’s disease, was tolerated well by healthy volunteers in a first-in-human clinical trial. The therapy’s developers — Nurron Pharmaceuticals, working in partnership with Hanall Biopharma and Daewoong Pharmaceutical — said they are planning a trial to…

Chaperone proteins may help lower alpha-synuclein in Parkinson’s

Higher levels of proteins called chaperones are linked with lower levels of disease-driving toxic protein clumps in the brains of people with Parkinson’s disease, a new study shows. The findings suggest that increasing chaperone proteins may be a viable therapeutic strategy for Parkinson’s. Data from the study also revealed…

Side-to-side eye movement can improve stability in Parkinson’s

Side-to-side eye movements can help reduce body sway and improve postural stability in people with Parkinson’s disease, even though Parkinson’s patients generally have difficulty coordinating their eye movements, a new study reports. The study, “People with Parkinson’s Disease Are Able to Couple Eye Movements and Postural…

Cleveland Clinic named Parkinson’s Foundation Center of Excellence

The Cleveland Clinic’s Center for Neurological Restoration, which specializes in medical and surgical approaches for treating Parkinson’s disease and other neurological and movement disorders, has once again been recognized as a Center of Excellence by the Parkinson’s Foundation. It was previously awarded the designation in 2018. That designation…